603739 logo

Qingdao Vland Biotech INC. Stock Price

SHSE:603739 Community·CN¥3.4b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

603739 Share Price Performance

CN¥0
-13.39 (-100.00%)
CN¥0
-13.39 (-100.00%)
Price CN¥0

603739 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Good value with adequate balance sheet.

2 Risks
3 Rewards

Qingdao Vland Biotech INC. Key Details

CN¥1.4b

Revenue

CN¥780.5m

Cost of Revenue

CN¥620.5m

Gross Profit

CN¥542.4m

Other Expenses

CN¥78.1m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
0.31
44.29%
5.57%
36.2%
View Full Analysis

About 603739

Founded
2005
Employees
1522
CEO
Gang Chen
WebsiteView website
www.vlandgroup.com

Qingdao Vland Biotech INC. engages in the research and development, production, and sale of enzyme preparations, microecological preparations, and animal health products in China and internationally. It offers feed, industrial, and food enzymes; and probiotics, including aquaculture premixes, health products, and animal and plant probiotics. The company also offers animal vaccines and biological products, such as live and inactivated, and poultry and swine vaccines, as well as egg yolk antibodies; poultry drugs comprising anti-parastic, antiviral, and nutritional drugs, as well as disinfectants; and traditional Chinese veterinary medicines for scale and avian breeding, livestock, and laying hens. It serves agriculture, animal husbandry, textile, pulp and paper, health care, laundry, biofuel, household cleaning and detergents, food, animal feed, biofuel, environmental protection, washing, and other industries. Qingdao Vland Biotech INC. was incorporated in 2005 and is headquartered in Qingdao, China.

Recent 603739 News & Updates

Recent updates

No updates